Westrock Coffee Company's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Westrock Coffee Company reported revenue of $1.2B (+39.8% year on year) and net income of ($90.4M) (-12.6% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net sales | $1.2B | $850.7M | $864.7M | $867.9M |
| Costs of sales | $1.0B | $697.0M | $724.9M | $715.1M |
| Gross profit | $150.8M | $153.8M | $139.9M | $152.8M |
| Selling, general and administrative expense | $185.5M | $185.1M | $144.6M | $130.0M |
| Transaction, restructuring and integration expense | $9.5M | $13.8M | $14.6M | $13.2M |
| Loss (gain) on disposal of property, plant and equipment | $1.3M | ($1.7M) | $1.2M | $935.0K |
| Total operating expenses | $196.2M | $202.9M | $160.3M | $144.1M |
| Loss from operations | ($45.5M) | ($49.1M) | ($20.4M) | $8.7M |
| Interest expense | $55.7M | $33.9M | $29.2M | $35.5M |
| Change in fair value of warrant liabilities | $0 | ($7.0M) | ($10.2M) | $29.7M |
| Other, net | ($4.1M) | $413.0K | $1.4M | ($1.1M) |
| Loss before income taxes and equity in earnings from unconsolidated entities | ($97.1M) | ($76.4M) | ($40.8M) | — |
| Income tax expense (benefit) | ($1.7M) | $3.7M | ($6.4M) | $111.0K |
| Equity in (earnings) loss from unconsolidated entities | ($4.9M) | $192.0K | $100.0K | — |
| Net loss | ($90.4M) | ($80.3M) | ($34.6M) | ($55.5M) |
| Net loss attributable to shareholders | ($90.4M) | ($80.3M) | ($34.6M) | ($55.2M) |
| Amortization (accretion) of Series A Convertible Preferred Shares | 347.0K | 349.0K | -161.0K | -1.3M |
| Net loss attributable to common shareholders | ($90.1M) | ($79.9M) | ($34.7M) | ($77.6M) |
| Basic (in dollars per share) | -$0.94 | -$0.89 | -$0.43 | -$1.60 |
| Diluted (in dollars per share) | -$0.94 | -$0.89 | -$0.43 | -$1.60 |
| Basic (in shares) | 95.4M | 89.8M | 80.7M | 48.4M |
| Diluted (in shares) | 95.4M | 89.8M | 80.7M | 48.4M |
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 | Jun 30, 2025 · Q2 |
|---|---|---|---|---|
| Net sales | $305.7M | $308.8M | $354.8M | $280.9M |
| Costs of sales | $267.9M | $263.1M | $313.4M | $239.5M |
| Gross profit | $37.7M | $45.8M | $41.4M | $41.4M |
| Selling, general and administrative expense | $36.0M | $37.8M | $47.0M | $53.9M |
| Transaction, restructuring and integration expense | $3.2M | $3.7M | $3.0M | $2.5M |
| Loss (gain) on disposal of property, plant and equipment | ($43.0K) | $1.1M | $8.0K | — |
| Total operating expenses | $39.1M | $42.6M | $50.0M | $56.4M |
| Income (loss) from operations | ($1.4M) | $3.2M | ($8.6M) | ($15.0M) |
| Interest expense | $13.0M | $13.5M | $14.0M | $13.1M |
| Other, net | ($117.0K) | ($489.0K) | ($992.0K) | ($2.7M) |
| Loss before income taxes and equity in earnings from unconsolidated entities | ($14.2M) | ($9.9M) | ($21.7M) | ($25.4M) |
| Income tax expense (benefit) | ($400.0K) | $2.0M | ($122.0K) | ($370.0K) |
| Equity in (earnings) loss from unconsolidated entities | ($166.0K) | ($3.3M) | ($2.4M) | ($3.5M) |
| Net loss | ($13.7M) | ($8.5M) | ($19.1M) | ($21.6M) |
| Amortization (accretion) of Series A Convertible Preferred Shares | 87.0K | 86.0K | 88.0K | 86.0K |
| Net loss attributable to common shareholders | ($13.6M) | ($8.4M) | ($19.0M) | ($21.5M) |
| Basic (in dollars per share) | -$0.14 | -$0.09 | -$0.20 | -$0.23 |
| Diluted (in dollars per share) | -$0.14 | -$0.09 | -$0.20 | -$0.23 |
| Basic (in shares) | 97.6M | 97.0M | 95.6M | 94.7M |
| Diluted (in shares) | 97.6M | 97.0M | 95.6M | 94.7M |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $49.9M | $26.2M | $37.2M | $16.8M |
| Restricted cash | $21.2M | $9.4M | $644.0K | $9.6M |
| Accounts receivable, net of allowance for credit losses of $2,750 and $3,995, respectively | $94.1M | $99.6M | $99.2M | $101.6M |
| Inventories | $199.8M | $163.3M | $149.9M | $145.8M |
| Derivative assets | $15.0M | $19.7M | $13.7M | $15.1M |
| Prepaid expenses and other current assets | $16.4M | $15.4M | $12.5M | $9.2M |
| Total current assets | $396.4M | $333.6M | $313.1M | $298.1M |
| Property, plant and equipment, net | $483.6M | $467.0M | $344.0M | $185.2M |
| Goodwill | $116.1M | $116.1M | $116.1M | $114.0M |
| Intangible assets, net | $107.1M | $114.9M | $122.9M | $130.9M |
| Operating lease right-of-use assets | $60.3M | $63.4M | $67.6M | — |
| Other long-term assets | $12.5M | $6.8M | $7.8M | $18.0M |
| Total Assets | $1.2B | $1.1B | $971.5M | $746.2M |
| Current maturities of long-term debt | $19.3M | $14.1M | $9.8M | $11.5M |
| Short-term debt | $82.6M | $54.7M | $43.7M | $42.9M |
| Accounts payable | $91.2M | $84.3M | $69.1M | $116.7M |
| Supply chain finance program | $96.6M | $78.8M | $78.1M | — |
| Derivative liabilities | $28.6M | $12.0M | $3.7M | $7.6M |
| Accrued expenses and other current liabilities | $95.3M | $34.1M | $35.2M | $37.5M |
| Total current liabilities | $413.6M | $277.9M | $239.6M | $216.1M |
| Long-term debt, net | $360.7M | $325.9M | $223.1M | $162.5M |
| Convertible notes payable - related party, net | $60.8M | $49.7M | — | — |
| Deferred income taxes | $10.2M | $15.0M | $10.8M | $14.4M |
| Operating lease liabilities | $58.1M | $60.7M | $63.6M | — |
| Other long-term liabilities | $865.0K | $1.3M | $1.6M | $11.0M |
| Total liabilities | $904.3M | $730.4M | $583.6M | $459.5M |
| Series A Convertible Preferred Shares, $0.01 par value, 24,000 shares authorized, 23,511 shares and 23,511 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively, $11.50 liquidation value | 273.5M | 273.9M | 274.2M | 274.9M |
| Common stock, $0.01 par value, 300,000 shares authorized, 96,866 shares and 94,221 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | 969.0K | 942.0K | 880.0K | 750.0K |
| Additional paid-in-capital | $544.6M | $519.9M | $471.7M | $342.7M |
| Accumulated deficit | ($534.4M) | ($442.9M) | ($362.6M) | ($328.0M) |
| Accumulated other comprehensive income (loss) | ($13.0M) | $19.6M | $3.8M | ($6.1M) |
| Total shareholders' equity (deficit) | ($1.9M) | $97.5M | $113.7M | $9.3M |
| Total Liabilities, Convertible Preferred Shares and Shareholders' Equity | 1.2B | 1.1B | 971.5M | 746.2M |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $38.2M | $28.1M | $34.0M | $44.0M |
| Restricted cash | $10.1M | $13.9M | $14.4M | $8.4M |
| Accounts receivable, net of allowance for credit losses of $3,217 and $2,750, respectively | $76.7M | $83.2M | $97.7M | $85.7M |
| Inventories | $167.5M | $180.8M | $213.0M | $194.2M |
| Derivative assets | $24.4M | $23.5M | $14.0M | $28.2M |
| Prepaid expenses and other current assets | $13.3M | $14.5M | $20.6M | $16.2M |
| Total current assets | $330.3M | $344.0M | $393.6M | $376.6M |
| Property, plant and equipment, net | $459.2M | $472.5M | $485.1M | $480.7M |
| Goodwill | $116.1M | $116.1M | $116.1M | $116.1M |
| Intangible assets, net | $103.3M | $105.2M | $109.0M | $110.9M |
| Operating lease right-of-use assets | $61.4M | $62.7M | $60.9M | $62.0M |
| Other long-term assets | $15.5M | $15.3M | $13.2M | $11.2M |
| Total Assets | $1.1B | $1.1B | $1.2B | $1.2B |
| Current maturities of long-term debt | $22.6M | $20.7M | $17.9M | $16.5M |
| Short-term debt | $55.8M | $60.4M | $84.1M | $75.2M |
| Accounts payable | $68.2M | $85.2M | $75.7M | $75.8M |
| Supply chain finance program | $97.5M | $99.8M | $98.7M | $98.3M |
| Derivative liabilities | $7.4M | $14.9M | $30.7M | $35.1M |
| Accrued expenses and other current liabilities | $90.2M | $72.9M | $77.5M | $60.6M |
| Total current liabilities | $341.8M | $353.9M | $384.5M | $361.4M |
| Long-term debt, net | $365.5M | $375.4M | $383.5M | $377.6M |
| Convertible notes payable - related party, net | $64.8M | $60.9M | $49.8M | $49.7M |
| Deferred income taxes | $11.5M | $11.0M | $15.4M | $16.2M |
| Operating lease liabilities | $59.4M | $60.5M | $58.7M | $59.6M |
| Other long-term liabilities | $866.0K | $865.0K | $1.0M | $1.0M |
| Total liabilities | $843.8M | $862.6M | $893.0M | $865.6M |
| Series A Convertible Preferred Shares, $0.01 par value, 24,000 shares authorized, 23,511 shares and 23,511 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively, $11.50 liquidation value | 273.3M | 273.4M | 273.6M | 273.7M |
| Common stock, $0.01 par value, 300,000 shares authorized, 97,627 shares and 96,866 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | 976.0K | 976.0K | 968.0K | 947.0K |
| Additional paid-in-capital | $547.1M | $545.4M | $541.7M | $526.6M |
| Accumulated deficit | ($556.6M) | ($542.9M) | ($510.8M) | ($491.7M) |
| Accumulated other comprehensive income (loss) | ($22.8M) | ($23.7M) | ($20.4M) | ($17.6M) |
| Total shareholders' equity (deficit) | ($31.3M) | ($20.2M) | $11.4M | $18.2M |
| Total Liabilities, Convertible Preferred Shares and Shareholders' Equity (Deficit) | 1.1B | 1.1B | 1.2B | 1.2B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net loss | ($90.4M) | ($80.3M) | ($34.6M) | ($55.5M) |
| Depreciation and amortization | $55.8M | $34.7M | $26.6M | $24.2M |
| Equity-based compensation | $14.6M | $11.6M | $8.7M | $2.6M |
| Provision for credit losses | $1.9M | $2.3M | $979.0K | $1.8M |
| Amortization of deferred financing fees included in interest expense | $4.6M | $3.2M | $3.5M | $1.7M |
| Write-off of unamortized deferred financing fees | $137.0K | — | — | $4.3M |
| (Gain) loss on disposal of property, plant and equipment | $1.3M | ($1.7M) | $1.2M | $935.0K |
| Gain on de-consolidation of Rwanda Trading Company | ($2.3M) | — | — | — |
| Mark-to-market adjustments | $629.0K | ($4.6M) | ($104.0K) | $3.5M |
| Change in fair value of warrant liabilities | $0 | ($7.0M) | ($10.2M) | $29.7M |
| Foreign currency transactions | ($141.0K) | $598.0K | $1.9M | $667.0K |
| Deferred income tax expense (benefit) | ($3.1M) | $3.3M | ($6.5M) | ($2.0M) |
| Other | ($3.3M) | $1.3M | $2.5M | $1.2M |
| Accounts receivable | ($7.0M) | ($2.8M) | $1.7M | ($16.8M) |
| Inventories | ($46.9M) | ($6.6M) | $915.0K | ($46.8M) |
| Derivative assets and liabilities | ($6.0M) | $16.4M | $6.4M | ($22.9M) |
| Prepaid expense and other assets | $3.3M | $2.0M | ($1.9M) | ($15.5M) |
| Accounts payable | $34.5M | $5.7M | ($59.3M) | $27.6M |
| Accrued liabilities and other | $23.4M | $3.0M | ($5.8M) | $2.7M |
| Net cash used in operating activities | ($19.0M) | ($13.2M) | ($64.1M) | ($56.6M) |
| Additions to property, plant and equipment | ($88.8M) | ($159.6M) | ($164.6M) | ($63.3M) |
| Additions to intangible assets | ($174.0K) | ($173.0K) | ($173.0K) | ($167.0K) |
| Proceeds from sale of equity method investments and non-marketable securities | $500.0K | — | — | — |
| Acquisition of equity method investments and non-marketable securities, inclusive of cash contributed | ($3.0M) | — | — | — |
| Proceeds from sale of property, plant and equipment | $462.0K | $13.9M | $206.0K | $4.1M |
| Proceeds from deferred purchase price of sold trade receivables | $8.8M | — | — | — |
| Net cash used in investing activities | ($82.2M) | ($145.9M) | ($168.4M) | ($74.2M) |
| Payments on debt | ($126.5M) | ($181.2M) | ($199.2M) | ($438.6M) |
| Proceeds from debt | $185.9M | $278.1M | $258.5M | $328.5M |
| Payments on supply chain financing program | ($181.5M) | ($163.9M) | ($32.1M) | — |
| Proceeds from supply chain financing program | $199.3M | $164.6M | $110.2M | — |
| Proceeds from convertible notes payable | $18.5M | $22.0M | — | — |
| Proceeds from convertible notes payable - related party | $11.5M | $50.0M | — | $11.7M |
| Payment of debt issuance costs | ($4.0M) | ($3.3M) | ($3.2M) | ($6.0M) |
| Payment of convertible notes payable issuance costs | ($1.2M) | ($511.0K) | — | — |
| Net proceeds from (repayments of) repurchase agreements | $11.2M | ($7.7M) | ($6.3M) | $14.6M |
| Net change in unremitted cash collections from servicing factored receivables | $13.8M | — | — | — |
| Proceeds from issuance of common stock | $12.1M | $635.0K | $118.8M | $255.7M |
| Payment of equity issuance costs | ($181.0K) | ($10.0K) | ($1.0M) | ($24.0M) |
| Payment for taxes for net share settlement of equity awards | ($2.1M) | ($2.1M) | ($3.0M) | ($477.0K) |
| Net cash provided by financing activities | $136.7M | $156.6M | $244.2M | $134.7M |
| Effect of exchange rate changes on cash | ($49.0K) | $260.0K | ($360.0K) | ($344.0K) |
| Net increase (decrease) in cash and cash equivalents and restricted cash | $35.5M | ($2.3M) | $11.4M | $3.5M |
| Cash and cash equivalents and restricted cash at beginning of period | $35.6M | $37.8M | $26.4M | $22.9M |
| Cash and cash equivalents and restricted cash at end of period | $71.0M | $35.6M | $37.8M | $26.4M |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Net loss | ($22.2M) | ($8.5M) | ($67.9M) | ($48.8M) |
| Depreciation and amortization | $33.7M | $16.6M | $40.7M | $26.8M |
| Equity-based compensation | $3.3M | $1.7M | $11.7M | $8.1M |
| Provision for credit losses | $716.0K | $507.0K | $165.0K | ($22.0K) |
| Amortization of deferred financing fees included in interest expense | $2.5M | $1.3M | $2.7M | $1.8M |
| Write-off of unamortized deferred financing fees | $168.0K | — | $137.0K | $137.0K |
| Loss on disposal of property, plant and equipment | $1.1M | $1.1M | $15.0K | $7.0K |
| Mark-to-market adjustments | ($4.5M) | ($5.1M) | ($983.0K) | ($3.5M) |
| Deferred income tax expense (benefit) | $1.3M | $918.0K | $1.3M | $1.5M |
| Equity in (earnings) loss from unconsolidated entities | ($3.5M) | ($3.3M) | — | — |
| Other | $522.0K | $312.0K | ($4.8M) | ($2.7M) |
| Accounts receivable | $8.7M | $6.1M | ($3.9M) | $12.2M |
| Inventories | $34.5M | $18.3M | ($54.8M) | ($43.3M) |
| Derivative assets and liabilities | ($38.0M) | ($27.1M) | ($12.0M) | ($8.4M) |
| Prepaid expense and other assets | $5.8M | $3.7M | ($1.9M) | $1.5M |
| Accounts payable | ($21.5M) | ($8.0M) | $18.8M | $10.9M |
| Accrued liabilities and other | $12.3M | ($10.2M) | $17.4M | $17.3M |
| Net cash provided by (used in) operating activities | $14.9M | ($11.8M) | ($55.7M) | ($29.1M) |
| Additions to property, plant and equipment | ($13.6M) | ($7.1M) | ($79.9M) | ($61.8M) |
| Additions to intangible assets | ($49.0K) | ($23.0K) | ($85.0K) | ($40.0K) |
| Proceeds from sale of property, plant and equipment | $361.0K | $233.0K | $329.0K | $316.0K |
| Proceeds from deferred purchase price of sold trade receivables | $8.0M | $4.3M | $3.9M | — |
| Net cash used in investing activities | ($5.3M) | ($2.6M) | ($78.2M) | ($64.0M) |
| Payments on debt | ($75.6M) | ($39.7M) | ($61.2M) | ($46.8M) |
| Proceeds from debt | $60.3M | $33.2M | $161.9M | $131.4M |
| Payments on supply chain financing program | ($96.8M) | ($49.7M) | ($131.1M) | ($79.8M) |
| Proceeds from supply chain financing program | $97.7M | $52.9M | $150.9M | $99.3M |
| Payment of debt issuance costs | ($1.7M) | ($973.0K) | ($2.7M) | ($2.4M) |
| Net proceeds from (repayments of) repurchase agreements | ($7.3M) | ($4.7M) | $11.2M | $9.8M |
| Net change in unremitted cash collections from servicing factored receivables | ($7.9M) | ($4.7M) | $7.9M | — |
| Payment for taxes for net share settlement of equity awards | ($956.0K) | ($939.0K) | ($2.1M) | ($1.6M) |
| Net cash (used in) provided by financing activities | ($32.2M) | ($14.6M) | $146.7M | $109.9M |
| Effect of exchange rate changes on cash | ($4.0K) | ($3.0K) | ($49.0K) | ($52.0K) |
| Net increase (decrease) in cash and cash equivalents and restricted cash | ($22.7M) | ($29.0M) | $12.8M | $16.8M |
| Cash and cash equivalents and restricted cash at beginning of period | $71.0M | $71.0M | $35.6M | $35.6M |
| Cash and cash equivalents and restricted cash at end of period | $48.4M | $42.0M | $48.4M | $52.3M |
| Property, plant and equipment acquired but not yet paid | $6.3M | $10.7M | $8.6M | $10.3M |
| Amounts obtained as beneficial interest in sold trade receivables | $7.6M | $3.9M | $5.8M | — |
Westrock Coffee Company score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.